Engineering the perfect (bacterial) cancer therapy
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Bacterial therapies possess many unique mechanisms for treating cancer that are unachievable with standard methods. Bacteria can specifically target tumours, actively penetrate tissue, are easily detected and can controllably induce cytotoxicity. Over the past decade, Salmonella, Clostridium and other genera have been shown to control tumour growth and promote survival in animal models. In this Innovation article I propose that synthetic biology techniques can be used to solve many of the key challenges that are associated with bacterial therapies, such as toxicity, stability and efficiency, and can be used to tune their beneficial features, allowing the engineering of 'perfect' cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in certain cases, injection of intratumoral bacteria or their antigens may conversely provide immunostimulatory effects, as demonstrated by Coley’s toxins and recent developments in bacterial cancer therapy (5, 105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
In the citing paper
“BCT is re-gaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
From The microbiome and human cancer (2021) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guzman, L. M., Belin, D., Carson, M. J., & Beckwith, J. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4121-4130.1995 · Cited by 4,935
(1989) · PubMed · Cited by 3,343
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · cited 1×
“Many treatments, including chemotherapy and radiation, are toxic to normal tissue and cannot completely destroy all cancer cell”
BackgroundTumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Automated design of synthetic ribosome binding sites to control protein expression
Salis, H. M., Mirsky, E. A., & Voigt, C. A. (2009) · Nature Biotechnology · doi:10.1038/nbt.1568 · Cited by 1,844
CONTRIBUTION TO THE KNOWLEDGE OF SARCOMA
COLEY, W. B. (1891) · Annals of Surgery · doi:10.1097/00000658-189112000-00015 · Cited by 715
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614 · cited 1×
“This containment is one possible reason that attenuated Salmonella had limited success in reducing tumour growth in human trial”
BackgroundCombination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563 · cited 1×
“For propulsion and sensing, bacteria have flagella that enable tissue penetratio”
BackgroundCombinatorial engineering of intergenic regions in operons tunes expression of multiple genes
Pfleger, B. F., Pitera, D. J., Smolke, C. D., & Keasling, J. D. (2006) · Nature Biotechnology · doi:10.1038/nbt1226 · Cited by 536 · cited 1×
“, including gene copy number, promoter strength, optimized codons, bacterial metabolism, mRNA secondary structur”
Background
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
“Bacteria can bypass problems associated with poor selectivity and limited tumor penetrability of conventional cancer chemotherapies and can be finely engineered to sense and respond to the tumor microenvironment.(392) One strategy is to utilize the native bacterial cytotoxicity to kill cancer cells.”
BackgroundFusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
“the potential utility of bacterial cancer therapy (Forbes 2010), an approach that relies fundamentally on the availability of microbes”
BackgroundLu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
The microbiome and human cancer
Sepich-Poore, G. D., Zitvogel, L., Straussman, R., Hasty, J., Wargo, J. A., & Knight, R. (2021) · Science · doi:10.1126/science.abc4552 · Cited by 1,332
“Though historically contentious, BCT is regaining attention through synthetic biology techniques that programmatically limit systemic toxicities while enhancing regional antitumor immunity (105, 106).”
BackgroundTumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
Synchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
“Thus a synergistic effect may arise when bacteria are used to deliver drugs to the necrotic core of a tumor, while standard chemotherapy is used for the vascularized regions 11,26 .”
BackgroundProgrammable bacteria induce durable tumor regression and systemic antitumor immunity
Chowdhury, S., Castro, S., Coker, C., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2019) · Nature Medicine · doi:10.1038/s41591-019-0498-z · Cited by 724
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647
Metabolic modulation of tumours with engineered bacteria for immunotherapy
Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., et al. (2021) · Nature · doi:10.1038/s41586-021-04003-2 · Cited by 619
Bacteria-cancer interactions: bacteria-based cancer therapy
Duong, M. T.-Q., Qin, Y., You, S.-H., & Min, J.-J. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0297-0 · Cited by 519
Programmable probiotics for detection of cancer in urine
Danino, T., Prindle, A., Kwong, G. A., Skalak, M., Li, H., Allen, K., Hasty, J., & Bhatia, S. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3519 · Cited by 467
“Empirical studies dating back to the 19 th century suggested that bacteria can affect tumor growth (5), and recent work has demonstrated that microbes directly administered intravenously can grow selectively in tumors without adversely affecting the health of the host (6–8).”
Engineering bacteria as interactive cancer therapies
Gurbatri, C. R., Arpaia, N., & Danino, T. (2022) · Science · doi:10.1126/science.add9667 · Cited by 447
Engineering microrobots for targeted cancer therapies from a medical perspective
Schmidt, C. K., Medina-Sánchez, M., Edmondson, R. J., & Schmidt, O. G. (2020) · Nature Communications · doi:10.1038/s41467-020-19322-7 · Cited by 441
Micro‐/Nanorobots at Work in Active Drug Delivery
Luo, M., Feng, Y., Wang, T., & Guan, J. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201706100 · Cited by 440
Intratumoral injection of Clostridium novyi -NT spores induces antitumor responses
Roberts, N. J., Zhang, L., Janku, F., Collins, A., Bai, R.-Y., Staedtke, V., Rusk, A. W., Tung, D., Miller, M., Roix, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008982 · Cited by 400
“More recent work involved attenuated strains of Salmonella typhimurium and others (13, 14).”
BackgroundEmerging biomedical applications of synthetic biology
Weber, W., & Fussenegger, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3094 · Cited by 362
“Tools that will have a tremendous impact in future biomedical applications include: using light-activated triggers to bring about a precise therapeutic response in cells 65 , programming bacteria to seek and destroy cancer cells 128, 132, 133 and using synthetic circuitry to keep crucial metabolites at homeostatic lev…”
BackgroundMethodBioengineered and biohybrid bacteria-based systems for drug delivery
Hosseinidoust, Z., Mostaghaci, B., Yasa, O., Park, B.-W., Singh, A. V., & Sitti, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.09.007 · Cited by 368
“Bacterial cells possess unique capabilities thatmake themwellsuited as miniaturized physicians; they are self-propelled (enabling penetration into inaccessible tumor regions), can sense the local environment and respond to external signals (enabling precise spatio-temporal control of therapeutic action), and can be ex…”
BackgroundInfluentialFan, J., Peng, M., Wang, H., Zheng, H., Liu, Z., Li, C., Wang, X., Liu, X., Cheng, S., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201808278 · Cited by 363
Engineering living therapeutics with synthetic biology
Cubillos-Ruiz, A., Guo, T., Sokolovska, A., Miller, P. F., Collins, J. J., Lu, T. K., & Lora, J. M. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00285-3 · Cited by 356
Optically-controlled bacterial metabolite for cancer therapy
Zheng, D.-W., Chen, Y., Li, Z.-H., Xu, L., Li, C.-X., Li, B., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03233-9 · Cited by 324
Living Bacterial Hydrogels for Accelerated Infected Wound Healing
Ming, Z., Han, L., Bao, M., Zhu, H., Qiang, S., Xue, S., & Liu, W. (2021) · Advanced Science · doi:10.1002/advs.202102545 · Cited by 315
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Sedighi, M., Zahedi Bialvaei, A., Hamblin, M. R., Ohadi, E., Asadi, A., Halajzadeh, M., Lohrasbi, V., Mohammadzadeh, N., Amiriani, T., Krutova, M., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2148 · Cited by 308
Bacteria‐Based Cancer Immunotherapy
Huang, X., Pan, J., Xu, F., Shao, B., Wang, Y., Guo, X., & Zhou, S. (2021) · Advanced Science · doi:10.1002/advs.202003572 · Cited by 304
Chen, Q., Bai, H., Wu, W., Huang, G., Li, Y., Wu, M., Tang, G., & Ping, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b02182 · Cited by 304
Dzutsev, A., Badger, J. H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C. K., & Trinchieri, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052133 · Cited by 302
“therapies fail but also their tumor tropism and ability to proliferate and maintain favorable pharmacokinetics for an extended period of time (179).”
BackgroundInfluentialProbiotic-guided CAR-T cells for solid tumor targeting
Vincent, R. L., Gurbatri, C. R., Li, F., Vardoshvili, A., Coker, C., Im, J., Ballister, E. R., Rouanne, M., Savage, T., de los Santos-Alexis, K., et al. (2023) · Science · doi:10.1126/science.add7034 · Cited by 273
Yue, Y., Xu, J., Li, Y., Cheng, K., Feng, Q., Ma, X., Ma, N., Zhang, T., Wang, X., Zhao, X., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00886-2 · Cited by 264
Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268
Taherkhani, S., Mohammadi, M., Daoud, J., Martel, S., & Tabrizian, M. (2014) · ACS Nano · doi:10.1021/nn5011304 · Cited by 267
“coli (10 40 μm s (1)), which can overcome diffusion resistances in solid tumors with this range of velocities.(15,16)”
Fan, J.-X., Li, Z.-H., Liu, X.-H., Zheng, D.-W., Chen, Y., & Zhang, X.-Z. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05323 · Cited by 264
A programmable encapsulation system improves delivery of therapeutic bacteria in mice
Harimoto, T., Hahn, J., Chen, Y.-Y., Im, J., Zhang, J., Hou, N., Li, F., Coker, C., Gray, K., Harr, N., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01244-y · Cited by 260
Choi, W., Park, B., Choi, S., Oh, D., Kim, J., & Kim, C. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00627 · Cited by 252
Intratumoural microbiota: a new frontier in cancer development and therapy
Cao, Y., Xia, H., Tan, X., Shi, C., Ma, Y., Meng, D., Zhou, M., Lv, Z., Wang, S., & Jin, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01693-0 · Cited by 253
Ma, X., Liang, X., Li, Y., Feng, Q., Cheng, K., Ma, N., Zhu, F., Guo, X., Yue, Y., Liu, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37225-1 · Cited by 243
“For flow cytometry analysis, splenocytes were co-cultured with a CT-26-specific antigen peptide (AH1 [6-14], sequence: SPSYVYHQF) overnight.”
MethodNanotechnology intervention of the microbiome for cancer therapy
Song, W., Anselmo, A. C., & Huang, L. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0589-5 · Cited by 246
Li, Z., Wang, Y., Liu, J., Rawding, P., Bu, J., Hong, S., & Hu, Q. (2021) · Advanced Materials · doi:10.1002/adma.202102580 · Cited by 244
Chen, Q., Liu, X., Fan, J., Peng, S., Wang, J., Wang, X., Zhang, C., Liu, C., & Zhang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909806 · Cited by 236
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
New paradigm for tumor theranostic methodology using bacteria-based microrobot
Park, S. J., Park, S.-H., Cho, S., Kim, D.-M., Lee, Y., Ko, S. Y., Hong, Y., Choy, H. E., Min, J.-J., Park, J.-O., et al. (2013) · Scientific Reports · doi:10.1038/srep03394 · Cited by 230
Chen, F., Zang, Z., Chen, Z., Cui, L., Chang, Z., Ma, A., Yin, T., Liang, R., Han, Y., Wu, Z., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119226 · Cited by 218
Microrobotics and Microorganisms: Biohybrid Autonomous Cellular Robots
Alapan, Y., Yasa, O., Yigit, B., Yasa, I. C., Erkoc, P., & Sitti, M. (2019) · Annual Review of Control, Robotics, and Autonomous Systems · doi:10.1146/annurev-control-053018-023803 · Cited by 210
Synthetic biomarkers: a twenty-first century path to early cancer detection
Kwong, G. A., Ghosh, S., Gamboa, L., Patriotis, C., Srivastava, S., & Bhatia, S. N. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00389-3 · Cited by 209
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., Taylor, S. R., Jang, Y., Sivan, A., Rhee, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44776-4 · Cited by 199
Exploiting bacteria for cancer immunotherapy
Kwon, S.-Y., Thi-Thu Ngo, H., Son, J., Hong, Y., & Min, J.-J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00908-9 · Cited by 201
“Bacterial genera tested for such purposes in preclinical studies and clinical trials include Streptococcus , Clostridium , Bifidobacterium , Listeria , Escherichia , Lactobacillus and Salmonella 23,26,88 (Supplementary Table 2).”
InfluentialGenetically encoded reporters for hyperpolarized xenon magnetic resonance imaging
Shapiro, M. G., Ramirez, R. M., Sperling, L. J., Sun, G., Sun, J., Pines, A., Schaffer, D. V., & Bajaj, V. S. (2014) · Nature Chemistry · doi:10.1038/nchem.1934 · Cited by 200
Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β
Kim, J.-E., Phan, T. X., Nguyen, V. H., Dinh-Vu, H.-V., Zheng, J. H., Yun, M., Park, S.-G., Hong, Y., Choy, H. E., Szardenings, M., et al. (2015) · Theranostics · doi:10.7150/thno.11432 · Cited by 200
“This approach has several advantages over other conventional therapies: bacteria have the ability to target tumors specifically; they actively proliferate in a variety of malignant tumors; they are easy to manipulate at the genetic level; and they are inexpensive to produce [2].”
BackgroundMagnetic torque–driven living microrobots for increased tumor infiltration
Gwisai, T., Mirkhani, N., Christiansen, M. G., Nguyen, T. T., Ling, V., & Schuerle, S. (2022) · Science Robotics · doi:10.1126/scirobotics.abo0665 · Cited by 189
“Outside the robotics community, the direct use of bacteria in cancer treatment has been investigated for more than a century, and a wide range of genetically engineered and attenuated strains have been tested in various animal models (6).”
BackgroundChen, Y., Du, M., Yuan, Z., Chen, Z., & Yan, F. (2022) · Nature Communications · doi:10.1038/s41467-022-31932-x · Cited by 189
“To date, many techniques have been developed for studying inducible gene expression in bacteria, including chemical induction, physical stimulation and biological methods 15,16 .”
MethodCell primitive-based biomimetic functional materials for enhanced cancer therapy
Luo, G.-F., Chen, W.-H., Zeng, X., & Zhang, X.-Z. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00152j · Cited by 193
Park, S.-H., Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Kim, D.-Y., Szardenings, M., Min, J. H., Hong, Y., Choy, H. E., & Min, J.-J. (2016) · Theranostics · doi:10.7150/thno.16135 · Cited by 176
“Some strains of bacteria naturally target tumors, including those of the breast, colon, pancreas, and prostate, as well as hepatocellular carcinoma, melanoma, neuroblastoma, and spinal cord glioma [1, 12, 30-32].”
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Souri, M., Soltani, M., Moradi Kashkooli, F., & Kiani Shahvandi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.024 · Cited by 178
Bacteria in Cancer Therapy: Renaissance of an Old Concept
Felgner, S., Kocijancic, D., Frahm, M., & Weiss, S. (2016) · International Journal of Microbiology · doi:10.1155/2016/8451728 · Cited by 175
Piñero-Lambea, C., Bodelón, G., Fernández-Periáñez, R., Cuesta, A. M., Álvarez-Vallina, L., & Fernández, L. Á. (2015) · ACS Synthetic Biology · doi:10.1021/sb500252a · Cited by 173
White paper on microbial anti-cancer therapy and prevention
Forbes, N. S., Coffin, R. S., Deng, L., Evgin, L., Fiering, S., Giacalone, M., Gravekamp, C., Gulley, J. L., Gunn, H., Hoffman, R. M., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0381-3 · Cited by 168
“A number of viruses from diverse genera have been developed into anticancer therapies, several genera of bacteria have been tested in preclinical studies, and a few bacterial platforms have been tested in clinical settings [18, 19].”
BackgroundSelf-citationBacteria and bacterial derivatives as drug carriers for cancer therapy
Cao, Z., & Liu, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.009 · Cited by 167
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
Savage, T. M., Vincent, R. L., Rae, S. S., Huang, L. H., Ahn, A., Pu, K., Li, F., de los Santos-Alexis, K., Coker, C., Danino, T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adc9436 · Cited by 161
“Bacteria are increasingly recognized as a component of the tumor microenvironment, with genetic manipulations of bacteria enabling renewed consideration for bacterial cancer therapy ( 20 – 22 ).”
The role of bacteria in cancer therapy – enemies in the past, but allies at present
Song, S., Vuai, M. S., & Zhong, M. (2018) · Infectious Agents and Cancer · doi:10.1186/s13027-018-0180-y · Cited by 160
“The tumor tissues that are deoxygenated nurture the accumulation of obligate anaerobic bacteria – which only survive in the anoxic region [23].”
BackgroundSynthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity
Ozdemir, T., Fedorec, A. J. H., Danino, T., & Barnes, C. P. (2018) · Cell Systems · doi:10.1016/j.cels.2018.06.008 · Cited by 159
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
Williams, E. M., Little, R. F., Mowday, A. M., Rich, M. H., Chan-Hyams, J. V. E., Copp, J. N., Smaill, J. B., Patterson, A. V., & Ackerley, D. F. (2015) · Biochemical Journal · doi:10.1042/bj20150650 · Cited by 171
Thanuja, M. Y., Anupama, C., & Ranganath, S. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.012 · Cited by 156
Yang, Y.-S., Hu, T., Bian, Y., Meng, F., Yu, S., Li, H., Zhang, Q., Gu, L., Weng, X., Tan, C., et al. (2023) · Advanced Materials · doi:10.1002/adma.202211205 · Cited by 156
Genetically engineered Salmonella Typhimurium: Recent advances in cancer therapy
Liang, K., Liu, Q., Li, P., Luo, H., Wang, H., & Kong, Q. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.037 · Cited by 154
Synthetic and living micropropellers for convection-enhanced nanoparticle transport
Schuerle, S., Soleimany, A. P., Yeh, T., Anand, G. M., Häberli, M., Fleming, H. E., Mirkhani, N., Qiu, F., Hauert, S., Wang, X., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4803 · Cited by 151
Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent
Jiang, S.-N., Park, S.-H., Lee, H. J., Zheng, J. H., Kim, H.-S., Bom, H.-S., Hong, Y., Szardenings, M., Shin, M. G., Kim, S.-C., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.183 · Cited by 153
Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy
Ou, M., Lin, C., Wang, Y., Lu, Y., Wang, W., Li, Z., Zeng, W., Zeng, X., Ji, X., & Mei, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.059 · Cited by 152
Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies
Wang, K., Kievit, F. M., & Zhang, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.016 · Cited by 169
Nguyen, V. D., Han, J., Choi, Y. J., Cho, S., Zheng, S., Ko, S. Y., Park, J., & Park, S. (2015) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2015.09.034 · Cited by 150
Anaerobe‐Inspired Anticancer Nanovesicles
Qian, C., Feng, P., Yu, J., Chen, Y., Hu, Q., Sun, W., Xiao, X., Hu, X., Bellotti, A., Shen, Q., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611783 · Cited by 149
Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions
Kramer, M. G., Masner, M., Ferreira, F. A., & Hoffman, R. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00016 · Cited by 145
“the actual location of transgene expression would allow the right selection of the gene, promoter, and secretion system (if required) to achieve optimized therapy (Forbes, 2010; Zheng et al., 2017).”
BackgroundMotility is critical for effective distribution and accumulation of bacteria in tumor tissue
Toley, B. J., & Forbes, N. S. (2011) · Integrative Biology · doi:10.1039/c2ib00091a · Cited by 160
Self-citationZhou, X. W., Zhang, X., Han, S., Dou, Y., Liu, M., Zhang, L., Guo, J., Shi, Q., Gong, G., Wang, R., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04523 · Cited by 152
Surface-modified bacteria: synthesis, functionalization and biomedical applications
Lin, S., Wu, F. Q., Zhang, Y., Chen, H., Guo, H., Chen, Y., & Liu, J. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00369h · Cited by 152
Carcinogenesis and therapeutics: the microbiota perspective
Tsilimigras, M. C. B., Fodor, A., & Jobin, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.8 · Cited by 144
Drug delivery with living cells
Fliervoet, L. A. L., & Mastrobattista, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.021 · Cited by 152
Unlocking the Potential of Magnetotactic Bacteria as Magnetic Hyperthermia Agents
Gandía, D., Gandarias, L., Rodrigo, I., Robles-García, J. L., Das, R., Garaio, E., García, J. Á., Phan, M., Srikanth, H., Orúe, I., et al. (2019) · Small · doi:10.1002/smll.201902626 · Cited by 143
Chen, H., Li, Y., Wang, Y., Ning, P., Shen, Y., Wei, X., Feng, Q., Liu, Y., Li, Z., Xu, C., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c11601 · Cited by 143
Recent Progress and Trends in X-ray-Induced Photodynamic Therapy with Low Radiation Doses
He, L., Yu, X., & Li, W. (2022) · ACS Nano · doi:10.1021/acsnano.2c07286 · Cited by 151
Clostridium novyi-NT in cancer therapy
Staedtke, V., Roberts, N. J., Bai, R.-Y., & Zhou, S. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2016.01.003 · Cited by 153
“Perturbations of tumor physiology and the resulting regions of hypoxia and necrosis, however, represent an ideal environment for anaerobic bacteria.(7) Specifically, anaerobic bacteria e or their spores e can be injected systemically or directly into the tumor and selectively grow in areas of hypoxia, resulting in tum…”
BackgroundBioinspired and biomimetic systems for advanced drug and gene delivery
Sabu, C., Rejo, C., Kotta, S., & Pramod, K. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.033 · Cited by 138
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
Feng, C., Tan, P., Nie, G., & Zhu, M. (2023) · Exploration · doi:10.1002/exp.20210263 · Cited by 158
Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
Yu, X., Lin, C., Yu, J., Qi, Q., & Wang, Q. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13523 · Cited by 158
Mostaghaci, B., Yasa, O., Zhuang, J., & Sitti, M. (2017) · Advanced Science · doi:10.1002/advs.201700058 · Cited by 131
Theranostic cells: emerging clinical applications of synthetic biology
McNerney, M. P., Doiron, K. E., Ng, T. L., Chang, T. Z., & Silver, P. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00383-3 · Cited by 141
Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope
Lou, X., Chen, Z., He, Z., Sun, M., & Sun, J. (2021) · Nano-Micro Letters · doi:10.1007/s40820-020-00560-9 · Cited by 138
Progress of engineered bacteria for tumor therapy
Fan, J.-X., Niu, M.-T., Qin, Y.-T., Sun, Y.-X., & Zhang, X.-Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114296 · Cited by 120
Transvascular transport of nanocarriers for tumor delivery
Li, X., Hu, Y. M., Zhang, X., Shi, X., Parak, W. J., & Pich, A. (2024) · Nature Communications · doi:10.1038/s41467-024-52416-0 · Cited by 160
“3c) 85 .”
Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies
Liu, X., Yin, L., Shen, S., & Hou, Y. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.09.006 · Cited by 137
Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy
Neubi, G. M. N., Opoku‐Damoah, Y., Gu, X., Han, Y., Zhou, J., & Ding, Y. (2018) · Biomaterials Science · doi:10.1039/c8bm00175h · Cited by 126
Precise Chemodynamic Therapy of Cancer by Trifunctional Bacterium-Based Nanozymes
Zhang, W., Liu, J., Li, X., Zheng, Y., Chen, L., Wang, D., Foda, M. F., Ma, Z., Zhao, Y., & Han, H. (2021) · ACS Nano · doi:10.1021/acsnano.1c05605 · Cited by 119
Murakami, T., DeLong, J. C., Eilber, F. C., Zhao, M. D., Zhang, Y., Zhang, N., Singh, A. S., Russell, T. A., Deng, S., Reynoso, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7226 · Cited by 116
“For example, in 1867, Busch reported that a malignant tumor disappeared when the patient contracted what is now known as Streptococcus pyogenes [4].”
Activation of inflammasome by attenuated Salmonella typhimurium in bacteria‐mediated cancer therapy
Phan, T. X., Nguyen, V. H., Duong, M. T., Hong, Y., Choy, H. E., & Min, J. (2015) · Microbiology and Immunology · doi:10.1111/1348-0421.12333 · Cited by 115
“This approach has several advantages over conventional therapies such as chemotherapy: bacteria have the ability to specifically target tumors, they actively proliferate in a variety of malignant tumors, they are easy to manipulate at the genetic level, and they are inexpensive to produce (2).”
BackgroundRemotely Activated Protein-Producing Nanoparticles
Schroeder, A., Goldberg, M. S., Kastrup, C., Wang, Y., Jiang, S., Joseph, B. J., Levins, C. G., Kannan, S. T., Langer, R., & Anderson, D. G. (2012) · Nano Letters · doi:10.1021/nl2036047 · Cited by 113
Schwarz, L., Medina‐Sánchez, M., & Schmidt, O. G. (2017) · Applied Physics Reviews · doi:10.1063/1.4993441 · Cited by 117
Engineered bacteria as therapeutic agents
Piñero‐Lambea, C., Ruano‐Gallego, D., & Fernández, L. Á. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.004 · Cited by 123
Cellular Biosensors with Engineered Genetic Circuits
Saltepe, B., Kehribar, E. Ş., YİRMİBEŞOĞLU, S. S. S., & Şeker, U. Ö. Ş. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00728 · Cited by 121
Customized materials-assisted microorganisms in tumor therapeutics
Chen, Q., Qiao, J., Liu, X., Zhang, C., & Zhang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01571g · Cited by 110
Massa, P. E., Paniccia, A., Monegal, A., de Marco, A., & Rescigno, M. (2013) · Blood · doi:10.1182/blood-2012-12-474098 · Cited by 107
“Indeed, a number of bacterial strains, including Clostridium, Bifidobacterium, and Salmonella, exhibit a remarkable tropism for tumors, indicating a therapeutic potential (reviewed by Forbes).(2) Although the precise mechanisms facilitating bacterial tumor colonization are unclear, both the leakiness of the tumor vasc…”
BackgroundAdvances in bacterial cancer therapies using synthetic biology
Chien, T., Doshi, A., & Danino, T. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.009 · Cited by 119
Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma
Pan, P., Dong, X., Chen, Y., Zeng, X., & Zhang, X. (2022) · ACS Nano · doi:10.1021/acsnano.1c08350 · Cited by 110
Anker, J. F., Naseem, A. F., Mok, H., Schaeffer, A. J., Abdulkadir, S. A., & Thumbikat, P. (2018) · Nature Communications · doi:10.1038/s41467-018-03900-x · Cited by 113
Metadata
- Authors
- Forbes, N. S.
- Affiliations
- University of Massachusetts Amherst (US)
- Corresponding author
- Forbes, Neil S.
- ORCID
- Forbes, Neil S.
- Venue
- Nature Reviews Cancer
- Published
- 2010-10-14
- Volume
- 10
- Issue
- 11
- Pages
- 785-794
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3756932
- OpenAlex
- W1979507175
- Cited by
- 905
- References
- 141
- Citations by year
- 2026: 76 · 2025: 89 · 2024: 95 · 2023: 76 · 2022: 81 · 2021: 81 · 2020: 69 · 2019: 47 · 2018: 47 · 2017: 46 · 2016: 42 · 2015: 40 · 2014: 45 · 2013: 37 · 2012: 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA120825, CA120825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- bacterial cancer therapy, synthetic biology, Salmonella, Clostridium, tumor targeting, bacterial cytotoxicity, bacterial stability, bacterial toxicity, tumor growth control, cancer immunotherapy
- MeSH terms
- Animals, Antineoplastic Agents, Clostridium, Genetic Engineering, Humans, Neoplasms, Salmonella
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.